The strained tricyclic benzoxa\[3.2.1\]octane skeleton exists in numerous bioactive and pharmaceutical molecules such as przewalskone[@b1] and brussonol[@b2], and it is a useful building block in organic synthesis such as for producing platensimycin[@b3] ([Fig. 1a](#f1){ref-type="fig"}). In recent decades, the significant biological activity and potential pharmaceutical value of molecules with this skeleton have driven chemists to devise several methods for constructing it ([Fig. 1b](#f1){ref-type="fig"})[@b3][@b4][@b5][@b6][@b7][@b8][@b9][@b10][@b11][@b12][@b13][@b14]. Nevertheless, more efficient and practical methods are needed.

One possible approach is the C--C bond formation via direct (sp^3^) α-C--H bond functionalization, which is increasingly being used to synthesize complex N- or O-containing molecules[@b15][@b16][@b17][@b18]. While several reactions have been described to achieve C--C formation at the α-position in amines, only a handful of reactions have been reported for C--C formation in ethers[@b19][@b20][@b21][@b22][@b23][@b24][@b25][@b26][@b27][@b28][@b29]. In connection with our long-standing interest in α-C--H bond functionalization of ethers[@b30][@b31] and in carbon--carbon rearrangement of allylic alcohol/silylether[@b32][@b33][@b34], we speculated that it might be possible to construct the benzoxa\[3.2.1\]octane unit via a tandem reaction that is initiated by benzylic C--H oxidation of an isochroman-derived allylic silylether and triggered by C--C bond rearrangement.

Here we use 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) and InCl~3~ to promote tandem C--H oxidation/cyclization/rearrangement of isochroman-derived allylic silylether. We then apply this efficient tandem reaction to asymmetric syntheses of the bioactive natural products (−)-brussonol and (−)-przewalskine *E*.

Results
=======

Reaction optimization
---------------------

We began our efforts to generate the benzoxa\[3.2.1\]octane unit using the model substrate **1a,** prepared as a single diastereoisomer in a general procedure (see [Supplementary Methods 1](#S1){ref-type="supplementary-material"} and [Supplementary Data 1 and 4](#S1){ref-type="supplementary-material"}). Initial experiment with the common oxidant DDQ (2.0 equiv.) as the sole promoter failed to give the desired product and resulted in fully recovery of **1a** ([Table 1](#t1){ref-type="table"}, entry 1). Next we tried combinations of DDQ (1.2 equiv.) and Lewis acids in the presence of 4-Å molecular sieve. Using FeCl~3~ or SnCl~4~ led to the decomposition of **1a** (entries 2 and 3), whereas using SnBr~4~ led to the consumption of 1**a** in 8 h and the desired product **2a** in 33% yield (entry 4). Cu(OTf)~2~ and LiClO~4~ also promoted this transformation, albeit in lower yield (entries 5 and 6). When 1.0 equiv. InCl~3~ was used, **2a** was obtained in 36% yield after 24 h and 15% of **1a** was recovered (entry 7). Increasing the load of DDQ to 2.0 equiv. gave higher yield (56%) in shorter time (4 h). Interestingly, decreasing the load of InCl~3~ to 0.1 equiv. further increased the yield of **2a** to 69% (entry 9). The molecular sieve was essential to this reaction, since omitting it led to only 30% yield (entry 10). With InCl~3~ as the catalyst, a side reaction in which **1a** was partially desilylated to give free allylic alcohol was always observed. To inhibit this, we screened several weakly basic additives (entries 11--14). We were pleased to find that using 2,6-dibromopyridine (DBP, 5.0 equiv.) significantly improved yield to 81% (entry 14). In addition, the reaction was also carried out in some other solvents (C~2~H~4~Cl~2~, CH~3~NO~2~, CH~3~CN, toluene, tetrahydrofuran (THF)) and oxidants (TEMPO, benzoquinone), but results were not better than with CH~2~Cl~2~ and DDQ. Therefore, the optimal conditions were defined to be DDQ (2.0 equiv.), InCl~3~ (0.1 equiv.), DBP (5.0 equiv.) and 4-Å molecular sieve in CH~2~Cl~2~ (entry 14, see [Supplementary Methods 2](#S1){ref-type="supplementary-material"}).

Substrate scope
---------------

Using these optimal reaction conditions, we tested the substrate scope of this transformation extensively ([Fig. 2](#f2){ref-type="fig"}), starting with the allylic substituents at R^1^. Substrates **1b** and **1c** with *n*-butyl and *i*-propyl groups at this position reacted well and gave the desired products **2b** and **2c** in respective yields of 80 and 83%. Benzyl-substituted **1d** also afforded the desired product **2d** in good 72% yield. In contrast, substrates with more electron-rich groups at R^1^ gave only medium to good yields. For example, substrates **1e** and **1f** with phenyl and vinyl substituents gave the corresponding products **2e** and **2f** in respective yields of 74 and 63% yield. The substrate **1g** with an acetylenyl substituent generated the product **2g** in a lower yield of 23%. Using substrate **1h** with a methyl substitution at the ally C=C led to smooth production of **2h** with a quaternary stereocenter in 83% yield. The product\'s relative configuration was confirmed by X-ray diffraction analysis. Next, the substituent effects on the aromatic ring of the isochroman moiety were investigated---compounds **1i** and **1j** fully substituted with MeO or Me reacted well, giving products **2i** and **2j** in respective yields of 83 and 87%. These relatively high yields may mean that the electron-donating methoxyl group stabilizes the benzylic oxonium carbocation in the transition state in [Fig. 1c](#f1){ref-type="fig"} better than hydrogen does. Compound **1k** with a bromo substituent at the 7th position in the isochroman moiety led to the desired product **2k** in 63% yield, extending the flexibility of our approach for further derivatization.

We also expanded the substrate scope to acyclic systems to allow the synthesis of multi-substituted THF derivatives, which exist in numerous bioactive and pharmaceutical molecules[@b35][@b36][@b37]. Four representative allylic siylethers **1l**--**1o** with terminal benzylic or allylic ethers as the reaction trigger generated the corresponding products **2l**--**2o** in 37--53% yields under the same optimal conditions. Notably, the reaction was triggered efficiently by either benzylic ethers (**1l**, **1m**, **1o**) or cinnamylic ethers. (**1n**) When a TBDPS ethylene ether was created in **1o** to compete with benzyl ether during the expected reaction, only the benzyl ether underwent reaction, affording the product **2o** in 42% yield. Under the same optimal conditions, yields were generally lower with acyclic substrates than with cyclic ones, which may be due to hyperoxidation of THF products that produced furan-type by-products ([Supplementary Methods 2.2](#S1){ref-type="supplementary-material"}).

Asymmetric syntheses of (−)-brussonol and (−)-przewalskine *E*
--------------------------------------------------------------

To further demonstrate the utility of this novel method for synthesizing polycyclic molecules, we applied it to the total synthesis of two important bioactive natural products---tetracyclic (−)-przewalskine *E* (**3a)** and (−)-brussonol (**3b**)[@b2][@b38][@b39][@b40]. Two diastereoselective routes to **3b** have been reported by Sarpong[@b41] and Jennings[@b42], while its asymmetric synthesis has been achieved by Majetich[@b43]. We are unaware of reports of the synthesis of **3a**. In our retrosynthetic analysis ([Fig. 3](#f3){ref-type="fig"}), we hypothesized that we could generate **3a** from **3b** via biomimetic oxidation, and that **3b** could be obtained from ketone intermediate **3c**. We planned to construct rings C and D in **3c** by applying our novel method to the tricyclic allylic siylether **3d,** which could be obtained from achiral allylic alcohol **3e** via a challenging tandem Sharpless asymmetric epoxidation/epoxy opening. The precursor **3e** could be prepared from the simple starting material **3f**[@b44] in a few short steps.

On the basis of this strategy, we started our synthesis by preparing allylic alcohol **3e** from bromide **3f** ([Fig. 4](#f4){ref-type="fig"}), which was formalized and protected as a 1,3-dioxane **3g** to survive subsequent metallization[@b45][@b46]. Deprotonation of **3g** with *n*-BuLi followed by quenching with formaldehyde and finally bromination of the resulting hydroxyl group with Ph~3~P/CBr~4~ gave benzyl bromide **3h** in 41% yield over two steps. Coupling bromide **3h** with vinyl triflate **3i**[@b47] and then removing the 1,3-dioxane protecting group in aqueous HCl afforded aldehyde **3j** in 69% yield over two steps. Excess diisobutylaluminum hydride (DIBAL-H) was used to reduce **3j** in a single step to diol **3e** in 93% yield. Then we investigated the key tandem Sharpless asymmetric epoxidation/epoxy opening of **3e**. The expected tricyclic species **3k** was obtained in 90% yield and 83% ee in the presence of classic Sharpless catalyst (1.5 equiv.) at −50 °C. While this enantioselectivity is not ideal, it appears to be a rare example of successful *tetra*-substituted olefin epoxidation[@b48]. Selective oxidation of the primary hydroxyl of **3k** followed by methylenenation afforded the desired tertiary allylic alcohol **3l**, which was protected to give the precursor **3d**. Fortunately, our optimal conditions of oxidative cyclization/ring enlargement gave the expected tetracyclic skeleton **3c** in high yield (81%) and excellent stereoselectivity, no other isomer was detected.

At this stage, only the installation of a gem-dimethyl group remained to complete the synthesis of **3b**. Initial attemps to transform the carbonyl in ketone **3c** directly into gem-dimethyl using TiMe~2~Cl~2~ reagent[@b49] gave the desired product **3o** in low yield. Therefore, we adopted a three-step protocol involving Wittig reaction, cyclopropanation and reduction. Treating **3c** with Ph~3~PCH~3~Br/*t*-BuOK followed by Simmons--Smith cyclopropanation of the resulting exo-cyclic olefin gave the cyclopropane compound **3n**, which was hydrogenated with H~2~ (1 atm)/PtO~2~ to afford the desired **3o** in 45% yield over three steps[@b50]. Demethylating **3o** using with EtSNa/DMF provided natural product **3b** in 76% yield, and the spectral data were identical to those reported by Sarpong[@b41] ([Supplementary Tables 1 and 2](#S1){ref-type="supplementary-material"}). We screened various oxidants for the biomimetic oxidation of **3b** to **3a**; Ag~2~O proved to be the best, affording the natural product **3a** in 71% yield. Its spectral data were identical to those reported by Zhao[@b40] ([Supplementary Tables 3 and 4](#S1){ref-type="supplementary-material"}).

Discussion
==========

The tandem C--H oxidation/cyclization/rearrangement of isochroman-derived allylic silylether described here shows good chemo- and stereoselectivity as well as good product yield. We demonstrated the usefulness of this approach by using it to achieve the asymmetric total syntheses of (−)-brussonol and (−)-przewalskine *E*. We expect that this approach will find additional applications in organic synthesis.

This approach involves simpler initiation and substrate preparation as well as milder reaction conditions than a similar acetal rearrangement under acidic conditions via alkoxy release reported by Overman\'s group[@b51][@b52][@b53][@b54][@b55][@b56][@b57][@b58]. Notably, we nearly always obtained the desired product with a benzoxa\[3.2.1\]octane framework as a single diastereomer ([Fig. 2](#f2){ref-type="fig"}). In term of the mechanism of this transformation, there are two possible pathways whereby intermediate **B** may react with a benzylic oxocarbenium cation under oxidative conditions ([Fig. 5](#f5){ref-type="fig"}). One is a tandem cyclization/semipinacol rearrangement to give **E** (pathway a) and the other is a tandem \[3,3\]-Cope rearrangement/aldol reaction (pathway b)[@b52]. Our results suggest that pathway b is more likely, since we did not obtain products with a benzoxa\[3.3.1\] skeleton when we used substrates **1e**, **1f**, **1g** or **1j**, all of which should preferentially undergo migration of an electron-rich R^1^ group when a semipinacol rearrangement process is involved. In addition, both substrates **1h** and **1h′**, which are epimers at the allylic position, gave a single diastereomeric product. Whether pathway b is the true one under our optimal conditions needs to be confirmed.

Methods
=======

Materials
---------

For NMR analysis, see [Supplementary Figs 1--136 and 139--154](#S1){ref-type="supplementary-material"}. For high-performance liquid chromatography traces, see [Supplementary Figs 137 and 138](#S1){ref-type="supplementary-material"}. For X-ray structures of the compounds, see [Supplementary Figs 155--158](#S1){ref-type="supplementary-material"}.

General
-------

All reactions under standard conditions were monitored by thin-layer chromatography. Column chromatography was performed on silica gel (200--300 mesh). Reaction solvents were distilled before use, and all air- or moisture-sensitive reactions were conducted under an argon atmosphere. Melting points were measured using a micro-melting point apparatus. Optical rotations were measured using a 0.1-ml cell with a 1-cm path length. ^1^H NMR and ^13^C NMR spectra were recorded in CDCl~3~ on a 400-MHz instrument (^1^H NMR) and a 100-MHz instrument (^13^C NMR); spectral data were reported in p.p.m. relative to trimethylsilane as the internal standard. Infrared spectra were recorded on a Fourier transform infrared spectrometer. High-resolution mass spectral analysis data were measured using the electrospray ionization technique on a Fourier transform ion cyclotron resonance mass analyser.

General procedure for this tandem reaction
------------------------------------------

To a solution of **1a** (249 mg, 0.78 mmol) in CH~2~Cl~2~ (8.0 ml), we successively added a 4-Å molecular sieve (400 mg), 2,6-DBP (924 mg, 3.90 mmol, 5.0 equiv.) and InCl~3~ (18 mg, 0.08 mmol, 0.1 equiv.) at room temperature under an argon atmosphere. The mixture was stirred for 15 min, then DDQ (361 mg, 98%, 1.56 mmol, 2.0 equiv.) was added. The resulting brown mixture was stirred for 12 h at room temperature before it was filtered via an SiO~2~ column with petroleum ether/EtOAc (4:1) as eluent to remove the molecular sieve and 2,6-DBP. The filtrate was concentrated under vacuum and chromatographed on an SiO~2~ column (petroleum ether/EtOAc, 10:1) to give product **2a** as a colourless oil (128 mg, 0.63 mmol, 81% yield).
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![Representative natural products containing benzoxa\[3.2.1\]octane skeleton and approaches to it.\
(**a**) Selected bioactive natural products having benzoxa\[3.2.1\]octane skeleton. (**b**) Previous methods for construction of benzoxa\[3.2.1\]octane skeleton. (**c**) Our synthetic proposal via a tandem C--H oxidation/cyclization/rearrangement reaction.](ncomms8332-f1){#f1}

![Reaction scope\*.\
\*All reactions unless notified were performed in experimental section procedure on a 0.1--1.5 mmol substrate scale in CH~2~Cl~2~ (0.1 mmol ml^−1^), 0.1 equiv. InCl~3~, 4 Å MS (50 mg per 0.1 mmol), 2.0 equiv. DDQ, 5.0 equiv. DBP at RT. Relative configuration of the products were assigned based on X-ray structure of **2h** and **2j** (CCDC 1000811, CCDC 1000827, See [Supplementary Data 2 and 3](#S1){ref-type="supplementary-material"} for more details). \*\*Isolated yields. \*\*\*1.1 equiv. DDQ was used.](ncomms8332-f2){#f2}

![Retrosynthetic analysis of **3a,b**.\
The current method was used to construct the core framework.](ncomms8332-f3){#f3}

![Asymmetric total synthesis of (−)-przewalskine *E* (3a) and (−)-brussonol (3b).\
Reagent and conditions: (**a**) *n*-BuLi, Et~2~O, −78 °C, then DMF; (**b**) 1,3-propanediol, CH(OEt)~3~, (*n*-Bu)~4~N^+^Br~3~^-^, 65 °C; 77% (2 steps); (**c**) *n*-BuLi, Hexane/Et~2~O, RT, then CH~2~O in THF, −78 °C; (**d**) Ph~3~P, CBr~4~, CH~2~Cl~2~, 0 °C, 41% (2 steps); (**e**) (i) Zn, THF, 0 °C to RT, then Pd(Ph~3~P)~2~Cl~2~, **3i** in DMF, 90 °C; (ii) 4 mol l^−1^ HCl, THF/H~2~O (4:1), 69% (2 steps); (**f**) DIBAL-H, CH~2~Cl~2~, −78 °C to RT, 93%; (**g**) (−)-DET, Ti(*i-*PrO)~4~, *t*-BuO~2~H, −25 °C to −50 °C, CH~2~Cl~2~, 90% yield, 83% ee; (**h**) DMSO, DIPEA, SO~3~·Py, CH~2~Cl~2~;(**i**) Ph~3~PCH~3~Br, *t*-BuOK, Tol, 72% (2 steps); (**j**) TBSOTf, Et~3~N, CH~2~Cl~2~, 0 °C to 40 °C, 98%; (**k**) 4 Å MS, 2,6-DBP, InCl~3~, DDQ, CH~2~Cl~2~, RT, 82%; (**l**) Ph~3~PCH~3~Br, *t*-BuOK, Toluene, 88%; (**m**) Et~2~Zn, CH~2~I~2~, Tol., 58%; (**n**) Pt~2~O, H~2~ (1 atm), AcOH, 65 °C, 89%; (**o**) EtSH, NaH, DMF, 150 °C, 76%; (**p**) Ag~2~O, Et~2~O, RT, 71%. DIPEA, *N*,*N*-diisopropylethylamine.](ncomms8332-f4){#f4}

![Proposed mechanism.\
(**a**) Tandem C--H bond oxidation/cyclization/semipinacol rearrangement reaction; (**b**) tandem C--H bond oxidation/\[3,3\]-Cope rearrangement/aldol reaction.](ncomms8332-f5){#f5}

###### Conditions optimization\*.
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